Financials
Financial year 2025
Gross margin
€ 2.9 million
▲ 16% vs 2024
Profit
Growing€ 2.1 million
▲ 16% vs 2024
Debts
Low€ 339,319
▼ 8% vs 2024
DEBA PHARMA from Kortrijk, company number BE0434737865, closed financial year 2025 with a result of € 2.1 million after tax. For that financial year DEBA PHARMA recorded a gross margin of € 2.9 million and equity of € 6.2 million. Compared with financial year 2024, the result moved from € 1.8 million to € 2.1 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
What happened at DEBA PHARMA?
What happened at DEBA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- JOHAN DEJONGHE stepped down as director. NBB
- INFICOM BV stepped down as director. NBB
- VINCENT DEJONGHE stepped down as director. NBB
- KRISTOF DEJONGHE stepped down as director. NBB
- FREDERIK DEJONGHE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.1 million (▲ 16% vs 2024). Source: NBB ↗
- JOHAN DEJONGHE became a director. NBB
- INFICOM BV became a director. NBB
In short
From € 1.2 million profit in 2021 to € 2.1 million profit in 2025.
Paid € 2.6 million in corporate taxes since 2021.
Best year ever: 2025, with € 2.1 million profit.
On average € 2.4 million of value added per employee in 2025.
A new publication or filing at DEBA PHARMA? We notify you, reason included.
Follow DEBA PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
since 2025 · until 2031
Director · represented by BAEKELANDT INGRID
since 2025 · until 2031
VINCENT DEJONGHE
Director
since 2025 · until 2031
KRISTOF DEJONGHE
Director
since 2025 · until 2031
FREDERIK DEJONGHE
Director
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
Dumolinlaan 13
8510 Kortrijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0434.737.865
- VAT number
- BE 0434.737.865
- Registered office
- Dumolinlaan 13, 8510 Kortrijk
- Names & denominations
- DEBA PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 15 July 1988
- Peppol
- Active · Active since 23 Dec 2025
- Contact
- debapharma.be
- Activities · NACE
Groothandel in andere voedingsmiddelen, neg
Overige gespecialiseerde groothandel in voedingswaren
Vervaardiging van geneesmiddelen
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen